Finally, we determined niclosamide’s anti-proliferative impact on SNU423 and SNU475 along with HepG2, a human HCC cell line lacking AR expression; THLE-2, an AR-negative immortalized normal human liver cell line; and primary male hepatocytes (Table 1, Figure S4) [5]. The gene discussed is AR; the disease is hepatocellular carcinoma.